Judith Anne Shizuru - Jul 3, 2025 Form 4 Insider Report for Jasper Therapeutics, Inc. (JSPR)

Role
Director
Signature
By: /s/ Herb Cross, as Attorney-in-Fact
Stock symbol
JSPR
Transactions as of
Jul 3, 2025
Transactions value $
$0
Form type
4
Date filed
7/3/2025, 04:24 PM
Previous filing
Jun 10, 2024
Next filing
Sep 24, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Shizuru Judith Anne Director C/O JASPER THERAPEUTICS, INC., 2200 BRIDGE PKWY, SUITE #102, REDWOOD CITY By: /s/ Herb Cross, as Attorney-in-Fact 2025-07-03 0001883000

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JSPR Stock Option (right to buy) Award $0 +7.5K $0.00 7.5K Jul 3, 2025 Voting Common Stock 7.5K $6.77 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Granted automatically pursuant to the Issuer's Non-Employee Director Compensation Policy, which provides that non-employee directors are automatically granted an option to purchase 7,500 shares on the date of each of the Issuer's annual meeting of stockholders.